In a recent Pharma Trends Outlook report, Dr. Sun Chau Siu, Executive Director & Head of Regulatory Affairs and Project Management at Altruist, shared his insights in a roundtable on the necessity of collaboration to establish regulatory frameworks around AI technologies as well as how companies are evolving their value chain resilience amidst changing geopolitics.

“The geopolitical landscape is increasingly complex and fluid. In response, companies are localizing operations in key hubs, while at the same time diversifying their footprints and building multiple hubs to reduce exposure to these uncertainties.”

Discover how the trends outlined in the 2026 Pharma Trends Outlook Report will not only redefine how medicines are discovered and delivered, but also shape the competitive dynamics of the sector for years to come.